Vasohibin attenuates bleomycin induced pulmonary fibrosis via inhibition of angiogenesis in mice

Pathology
Xingsheng WangShehuai Cui

Abstract

Much evidence suggests that vascular remodelling in the lung plays a crucial role in the development of pulmonary fibrosis. Therefore, anti-angiogenesis therapy may be a promising treatment for pulmonary fibrosis. Recently, a new inhibitor called vasohibin has been discovered to operate as an intrinsic and highly specific feedback inhibitor in the process of angiogenesis. However, to date, the effect of vasohibin on anti-angiogenesis of pulmonary fibrosis has not been examined. In this study, we utilised vasohibin to test the potential of pulmonary fibrosis therapy. We examined the role of vasohibin in the pathophysiology of bleomycin-induced pneumopathy in mice by transfection of the vasohibin gene. The results demonstrated that transfection of the vasohibin gene could attenuate pulmonary fibrosis via inhibition of angiogenesis, which markedly decreased lymphocyte infiltration, cytokine secretion and fibroblast proliferation. This method may be beneficial for treating lung fibrosis and may provide a novel strategy for clinical application in the future.

References

Jan 1, 1988·Journal of Cell Science. Supplement·B I Lord
Aug 5, 2000·Current Opinion in Nephrology and Hypertension·R Kalluri, V P Sukhatme
Dec 26, 2001·American Journal of Respiratory and Critical Care Medicine·M P KeaneR M Strieter
Mar 13, 2002·General Pharmacology·D RibattiM Presta
Oct 3, 2002·Nature Reviews. Cancer·Napoleone Ferrara
Nov 27, 2002·The European Respiratory Journal·M T HenryC M O'Connor
Sep 1, 1963·Thorax·M TURNER-WARWICK
Oct 7, 2004·The Journal of Clinical Investigation·Robert S Kerbel
Oct 7, 2004·The Journal of Clinical Investigation·Kazuhide WatanabeYasufumi Sato
May 3, 2005·The Journal of Clinical Investigation·Ivor S Douglas, Mark R Nicolls
Jul 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Naoki HamadaYoichi Nakanishi
Nov 25, 2005·The New England Journal of Medicine·Gary W Hunninghake
May 19, 2006·Biochemical and Biophysical Research Communications·Hiroshi YamashitaYasufumi Sato
Mar 16, 2007·Chest·Norbert F VoelkelMark Nicolls
Oct 27, 2007·American Journal of Respiratory and Critical Care Medicine·Katerina M AntoniouAthol U Wells
Mar 28, 2008·Orphanet Journal of Rare Diseases·Eric B Meltzer, Paul W Noble
Apr 1, 2008·The International Journal of Biochemistry & Cell Biology·Annika Andersson-SjölandMoisés Selman
Apr 9, 2008·The International Journal of Biochemistry & Cell Biology·Lynne A MurrayAnuk M Das
May 13, 2008·European Journal of Internal Medicine·Ritesh Agarwal, Surinder K Jindal
May 20, 2008·American Journal of Ophthalmology·Ryosuke WakusawaKohji Nishida
Sep 17, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·S Huerta-YepezB Bonavida
Feb 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Souheil El-ChemalyJoel Moss

❮ Previous
Next ❯

Citations

Oct 27, 2012·Journal of Biochemistry·Yasufumi Sato
Aug 26, 2014·Experimental Lung Research·Zulma X YuntWilliam J Janssen
Apr 29, 2014·Expert Opinion on Investigational Drugs·Sushmita ChakrabortyAbhijit Ray
Mar 24, 2012·PloS One·Joshua J FieldRobert M Strieter
Mar 1, 2012·PloS One·Samuel L CollinsMaureen R Horton
Jun 29, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hu ZhaoJin Su
Jun 21, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ariel Johnson, Luisa Ann DiPietro
Jun 29, 2014·Physiological Reports·Hiroyuki WatataniHirofumi Makino
Aug 20, 2019·Respiratory Medicine·Ankit P Laddha, Yogesh A Kulkarni
Feb 23, 2021·Molecular Therapy. Methods & Clinical Development·Mitchel J R RuigrokWouter L J Hinrichs
Apr 22, 2021·Therapeutic Advances in Respiratory Disease·Shixue SunXiaohua Douglas Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.